BRAF and melanoma: Together, these data demonstrate that the sensitivity of BRAF-mutant melanoma cells to SP2509 and JIB-04 can be predicted based on their differentiation state (Ngfr versus Axl) and the relative levels of Znf217 and Kdm4b proteins.